Back

Independent Generation of Amyloid-β via Novel APP Transcripts

Gustavsson, E. K.; Abel, E.; Macpherson, H.; Brinkmalm, G.; Piotrowska, D.; Wagen, A. Z.; Montgomery, K.; Villegas Llerena, C.; Alvarez Giovannucci, T.; de Silva, R.; Heslegrave, A.; Fox, N.; Zetterberg, H.; Houlden, H.; Hardy, J.; Wray, S.; Arber, C.; Ryten, M.

2025-05-14 neuroscience
10.1101/2025.05.13.651054 bioRxiv
Show abstract

The amyloid precursor protein (APP) is processed by multiple enzymes to generate biologically active peptides, including amyloid-{beta} (A{beta}), which aggregates to form the hallmark pathology of Alzheimers disease (AD). A{beta} is produced through an initial {beta}-secretase cleavage of APP, generating a 99-amino acid C-terminal fragment (APP-C99). Subsequent cleavage of APP-C99 by {gamma}-secretase produces A{beta} peptides of varying lengths. To better understand the transcriptional regulation of A{beta} production, we employed long-read RNA sequencing and identified previously unannotated transcripts encoding APP-C99 with an additional methionine residue (APP-C100), generated independently of {beta}-secretase cleavage. These transcripts are expressed separately from full-length APP, and we observed that cells lacking full-length APP can still produce A{beta} through these shorter isoforms. Importantly, mass spectrometry analysis of cerebrospinal fluid (CSF) revealed peptides consistent with the methionine-extended A{beta} species, supporting the in vivo translation of these transcripts. Our findings reveal an alternative pathway for A{beta} generation and aggregation, highlighting a potential new target for modulating A{beta} accumulation in AD.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.